Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Neurosurgery

The Two Stages of Injury: Why the First Few Days Matter

At a Glance

A spinal cord injury occurs in two distinct stages. The primary injury is the immediate physical trauma to the spinal cord. This triggers a secondary injury cascade—a biological chain reaction of swelling and inflammation that occurs over the following days, causing further nerve damage.

To understand a spinal cord injury (SCI), it helps to view it not as a single event, but as a two-stage process. While the initial accident causes immediate damage, a second, invisible biological “storm” follows in the hours and days afterward [1][2]. This two-phase model is why the first few days of medical care are so critical.

Phase 1: The Primary Injury

The primary injury is the initial mechanical trauma—the moment the spinal cord is stretched, compressed, or torn by bone fragments or outside force [3].

  • What happens: This physical force immediately destroys some nerve cells (neurons) and the protective insulation around them (myelin), much like a cable being frayed or crushed [1].
  • The result: Communication between the brain and the body is interrupted instantly at the site of the impact [4].

Phase 2: The Secondary Injury Cascade

Shortly after the accident, a complex chain reaction called the secondary injury cascade begins [5]. If the primary injury is like a car crash, the secondary injury is like the fire that breaks out afterward, potentially causing more damage than the initial impact [1][2].

Several biological events drive this cascade:

  • Blood-Spinal Cord Barrier Breakdown: The spinal cord has a protective filter called the blood-spinal cord barrier that keeps harmful substances out [6]. The injury breaks this barrier, allowing inflammatory cells and toxins from the blood to flood into the delicate nerve tissue, causing significant swelling (edema) [7][8].
  • Excitotoxicity: When cells are damaged, they leak a chemical called glutamate [9]. In small amounts, glutamate helps nerves “talk,” but in large amounts, it becomes toxic, overstimulating and killing neighboring healthy cells [10].
  • Neuroinflammation: Your immune system rushes to the site of the injury. While intended to help, this massive inflammatory response often backfires, releasing chemicals that further damage surviving nerves [11][12].
  • Apoptosis (Programmed Cell Death): Cells that weren’t destroyed in the initial crash may “decide” to die due to the harsh environment created by the inflammation and lack of oxygen [13][5].

Why This Matters for Your Care

Most acute medical treatments—such as surgery to stabilize the spine or medications to manage blood pressure—are designed to interrupt this secondary cascade [14][15].

Researchers are currently looking for ways to “dampen” this biological storm. Future treatments may include:

  1. Neuroprotective Drugs: Medications like Riluzole that aim to block the toxic buildup of glutamate [9].
  2. Barrier Stabilization: Techniques to “patch” the blood-spinal cord barrier and reduce swelling [16].
  3. Advanced Scaffolding: Using biomaterials to help bridge the gap created by the injury and support surviving nerves [17].

By understanding that your body is working through these complex stages, you can better appreciate why early, intensive medical monitoring is so vital for preserving as much function as possible [18].

Common questions in this guide

What is the difference between a primary and secondary spinal cord injury?
The primary injury is the immediate physical damage from an accident that stretches or compresses the spinal cord. The secondary injury is a biological chain reaction of swelling, inflammation, and cellular toxicity that follows in the hours and days after the initial trauma.
Why is early treatment for a spinal cord injury so important?
Early medical interventions, such as surgery to stabilize the spine or medications to control blood pressure, are designed to interrupt the secondary injury cascade. Stopping this biological storm helps prevent further swelling and preserves as much nerve function as possible.
What causes swelling after a spinal cord injury?
Swelling, or edema, happens when the protective blood-spinal cord barrier breaks down after the initial trauma. This breakdown allows inflammatory cells and fluids from the blood to flood into the delicate nerve tissue, which can damage surviving cells.
What are neuroprotective drugs for spinal cord injuries?
Neuroprotective drugs are medications that aim to protect surviving nerve cells during the secondary injury cascade. For example, some drugs work by blocking the toxic buildup of chemicals like glutamate, preventing them from destroying healthy cells.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Based on my imaging, how much of my current symptoms are likely due to initial mechanical damage versus ongoing swelling (edema)?
  2. 2.What medications am I receiving to help manage the secondary injury cascade, such as anti-inflammatories or neuroprotective agents?
  3. 3.How are we monitoring my spinal cord's blood flow and oxygenation to prevent further secondary damage?
  4. 4.Are there any clinical trials at this facility targeting the secondary injury phase that I might be eligible for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Subacute Posttraumatic Ascending Myelopathy After an Incomplete Spinal Cord Injury from a Gunshot Wound to the Spine: Case Report and Review of the Literature.

    Miller BA, Roy AK, Boucher AB, et al.

    World neurosurgery 2016; (88()):687.e13-687.e17 doi:10.1016/j.wneu.2015.11.058.

    PMID: 26704212
  2. 2

    Cell biology of spinal cord injury and repair.

    O'Shea TM, Burda JE, Sofroniew MV

    The Journal of clinical investigation 2017; (127(9)):3259-3270.

    PMID: 28737515
  3. 3

    Pharmacologic and Acute Management of Spinal Cord Injury in Adults and Children.

    Thomas AX, Riviello JJ, Davila-Williams D, et al.

    Current treatment options in neurology 2022; (24(7)):285-304 doi:10.1007/s11940-022-00720-9.

    PMID: 35702419
  4. 4

    Early Predictors of Neurological Outcomes After Traumatic Spinal Cord Injury: A Systematic Review and Proposal of a Conceptual Framework.

    Mputu Mputu P, Beauséjour M, Richard-Denis A, Mac-Thiong JM

    American journal of physical medicine & rehabilitation 2021; (100(7)):700-711 doi:10.1097/PHM.0000000000001701.

    PMID: 34131094
  5. 5

    Machine Learning and Experiments Revealed Key Genes Related to PANoptosis Linked to Drug Prediction and Immune Landscape in Spinal Cord Injury.

    Li B, Li T, Cai Y, et al.

    Molecular neurobiology 2025; (62(6)):7364-7379 doi:10.1007/s12035-025-04717-8.

    PMID: 39888480
  6. 6

    Propitious Therapeutic Modulators to Prevent Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

    Kumar H, Ropper AE, Lee SH, Han I

    Molecular neurobiology 2017; (54(5)):3578-3590 doi:10.1007/s12035-016-9910-6.

    PMID: 27194298
  7. 7

    Neutrophil Extracellular Traps Exacerbate Secondary Injury via Promoting Neuroinflammation and Blood-Spinal Cord Barrier Disruption in Spinal Cord Injury.

    Feng Z, Min L, Liang L, et al.

    Frontiers in immunology 2021; (12()):698249 doi:10.3389/fimmu.2021.698249.

    PMID: 34456910
  8. 8

    Aquaporin-4 expression dynamically varies after acute spinal cord injury-induced disruption of blood spinal cord barrier in rats.

    Pan YL, Guo Y, Ma Y, et al.

    Neuropathology : official journal of the Japanese Society of Neuropathology 2019; (39(3)):181-186 doi:10.1111/neup.12539.

    PMID: 30919512
  9. 9

    Neuroprotective Riluzole-Releasing Electrospun Implants for Spinal Cord Injury.

    Ullrich MM, Pulipaka B, Yin J, et al.

    Molecular pharmaceutics 2025; (22(6)):2905-2916 doi:10.1021/acs.molpharmaceut.4c01270.

    PMID: 40378306
  10. 10

    A Review of Pathophysiology, Molecular Mechanisms, and Omics Approaches of Spinal Cord Injury.

    Patel M, Deng AJ, Hasoon J, et al.

    International journal of molecular sciences 2025; (26(16)) doi:10.3390/ijms26167895.

    PMID: 40869215
  11. 11

    Targeting RelA/NLRP3/CCL3 axis mitigates microglia inflammatory response and promotes recovery after spinal cord injury.

    Song W, Fu R, Yuan Z, et al.

    Brain, behavior, and immunity 2025; (129()):801-817 doi:10.1016/j.bbi.2025.07.015.

    PMID: 40691997
  12. 12

    Bibliometric analysis of the inflammation expression after spinal cord injury: current research status and emerging frontiers.

    Li X, Jiao K, Liu C, et al.

    Spinal cord 2024; (62(11)):609-618 doi:10.1038/s41393-024-01038-w.

    PMID: 39363043
  13. 13

    Biomaterial-based strategies: a new era in spinal cord injury treatment.

    Zhu S, Diao S, Liu X, et al.

    Neural regeneration research 2025; (20(12)):3476-3500 doi:10.4103/NRR.NRR-D-24-00844.

    PMID: 40095657
  14. 14

    Acute Traumatic Spinal Cord Injury.

    Eli I, Lerner DP, Ghogawala Z

    Neurologic clinics 2021; (39(2)):471-488 doi:10.1016/j.ncl.2021.02.004.

    PMID: 33896529
  15. 15

    The use of classification tree analysis to assess the influence of surgical timing on neurological recovery following severe cervical traumatic spinal cord injury.

    Facchinello Y, Richard-Denis A, Beauséjour M, et al.

    Spinal cord 2018; (56(7)):687-694 doi:10.1038/s41393-018-0073-3.

    PMID: 29483585
  16. 16

    Small extracellular vesicles released by infused mesenchymal stromal cells target M2 macrophages and promote TGF-β upregulation, microvascular stabilization and functional recovery in a rodent model of severe spinal cord injury.

    Nakazaki M, Morita T, Lankford KL, et al.

    Journal of extracellular vesicles 2021; (10(11)):e12137 doi:10.1002/jev2.12137.

    PMID: 34478241
  17. 17

    Research Progress on Biomaterials for Spinal Cord Repair.

    Liao Z, Bao Q, Saijilahu , et al.

    International journal of nanomedicine 2025; (20()):1773-1787 doi:10.2147/IJN.S501121.

    PMID: 39958319
  18. 18

    MRI in traumatic spinal cord injury: from clinical assessment to neuroimaging biomarkers.

    Freund P, Seif M, Weiskopf N, et al.

    The Lancet. Neurology 2019; (18(12)):1123-1135 doi:10.1016/S1474-4422(19)30138-3.

    PMID: 31405713

This page provides educational information about the biological stages of a spinal cord injury. It does not replace professional medical advice from your trauma care team or neurosurgeon.

Get notified when new evidence is published on Spinal cord injury.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.